Concepedia

Marion Chevandier

MC

Statistics

Publications

3

Citations

70

H-Index

3

Active since

2021

Affiliations

Abivax (France)(Current)

Marion Chevandier is an author at Abivax (France) specializing in virology, vaccine development, and t cell immunity.

Top concepts

Publications per year

2021–2023

3

Publications

3

OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model

Charlotte Primard, Élodie Monchâtre-Leroy, Judith del Campo et al. · Frontiers in Immunology · 2023 · 29 citations · Full text

OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza

Judith del Campo, Julien Bouley, Marion Chevandier et al. · Frontiers in Immunology · 2021 · 24 citations · Full text

, , +20

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results

Kanchanamala Withanage, Ilse De Coster, Nathalie Cools et al. · The Journal of Infectious Diseases · 2021 · 17 citations · Full text

1–3 of 3